BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36597332)

  • 1. Adult Vanishing White Matter Disease with a Novel EIF2B4 Mutation.
    Su T; Yuan H; Gao W; Li H; Yuan M
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS181-SS183. PubMed ID: 36597332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
    Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
    BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
    Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
    J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
    Alsalem A; Shaheen R; Alkuraya FS
    Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
    Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
    Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of eIF2B bodies and their relationships with stress granules and P-bodies.
    Moon SL; Parker R
    Sci Rep; 2018 Aug; 8(1):12264. PubMed ID: 30115954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukodystrophy Due to
    Shivaram S; Nagappa M; Seshagiri DV; Saini J; Govindaraj P; Sinha S; Bindu PS; Taly AB
    Can J Neurol Sci; 2022 Sep; 49(5):708-712. PubMed ID: 34663487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and
    Trevisan L; Grazzini M; Cianflone A; Accogli A; Finocchi C; Capello E; Saitta L; Grandis M; Roccatagliata L; Mandich P
    Neurocase; 2021 Dec; 27(6):452-456. PubMed ID: 34751098
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Moon SL; Parker R
    RNA; 2018 Jun; 24(6):841-852. PubMed ID: 29632131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.
    Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C
    Elife; 2018 Feb; 7():. PubMed ID: 29489452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
    Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
    J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult Onset Disease.
    Barros SR; Parreira SCR; Miranda AFB; Pereira AMB; Campos NMP
    J Neuroophthalmol; 2018 Mar; 38(1):42-46. PubMed ID: 28902089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene].
    Sinkó G; Tompa M; Kiss Z; Kálmán B
    Ideggyogy Sz; 2024 May; 77(5-6):207-211. PubMed ID: 38829246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare mutation in EIF2B4 gene in an epileptic child with vanishing white matter disease: a case report.
    Gungor O; Ozkaya AK; Hirfanoglu T; Dilber C; Aydin K
    Genet Couns; 2015; 26(1):41-6. PubMed ID: 26043506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
    Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
    Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease.
    Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T
    Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
    La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
    Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.